P1.15-19 Treatment of Choice for First-Line Therapy of EGFR-Mutated Stage IIIB Lung Adenocarcinoma Based on the Real World Data

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.951
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV